Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 2, 2013, Pages 227-234

  Skert, Cristina ^a   Fogli, Manuela ^a   Perucca, Simone ^a   Garrafa, Emirena ^a   Fiorentini, Simona ^a   Filì, Carla ^a   Bergonzi, Cesare ^a   Malagola, Michele ^a   Turra, Alessandro ^a   Colombi, Chiara ^a   Cattina, Federica ^a   Alghisi, Elisa ^a   Caruso, Arnaldo ^a   Russo, Domenico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Lymphocyte; Monocyte; Toll like receptor

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 4; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; MALE; MONOCYTE; PREDICTOR VARIABLE; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; T LYMPHOCYTE;

ACUTE DISEASE; ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84872607599     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.09.013     Document Type: Article

References (48)

1. Paczesny S., Hanauer D., Sun Y., et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010, 45:1-11.
2. Hill G.R., Ferrara J.L. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000, 95:2754-2759.
3. Penack O., Holler E., van den Brink M.R.M. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood 2010, 115:1865-1872.
4. + cells before starting conditioning regimen correlate with greater risk of acute GVHD in allogeneic stem cell transplant from related donors. Biol Blood Marrow Transplant 2007, 13:228-234.
5. Chang Z.L. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res 2010, 59:791-808.
6. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
7. Hornung V., Rothenfusser S., Britsch S., et al. Quantitative expression of Toll-like receptors 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4537.
8. Blasius A.L., Beutler B. Intracellular Toll-like receptors. Immunity 2010, 32:305-315.
9. Hedayat M., Takeda K., Rezaei N. Prophylactic and therapeutic implications of Toll-like receptor ligands. Med Res Rev 2012, 32:294-325.
10. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
11. Poutsiaka D.D., Munson D., Price L.L., et al. Bloodstream infection (BSI) and acute graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT) are associated. Bone Marrow Transplant 2011, 46:300-307.
12. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974, 18:295-304.
13. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
14. Ghosh T.K., Mickelson D.J., Fink J., et al. Toll-like receptor (TLR) 2-9 agonist-induced cytokines and chemokines, I: comparison with T cell receptor-induced responses. Cell Immunol 2006, 243:48-57.
15. Skert C., Damiani D., Michelutti A., et al. Kinetics of Th1/Th2 cytokines and lymphocyte subset to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant 2009, 44:729-737.
16. Jolliffe I.T. Principal Component Analysis 2002, Springer, New York. 2nd ed.
17. Papadimitraki E.D., Bertsias G.K., Boumpas D.T. Toll-like receptors and autoimmunity: a critical appraisal. J Autoimmun 2007, 29:310-318.
18. Krug A. Nucleic Acid Recognition Receptors in Autoimmunity 2008, 129-151. Springer, Berlin and Heidelberg, Germany. S. Bauer, G. Hartmann (Eds.).
19. Lorenz E., Schwartz D.A., Martin P.J., et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001, 7:384-387.
20. Elmaagacli A.H., Koldehoff M., Hindahl H., et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399IIe) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006, 81:247-254.
21. Elmaagacli A.H., Koldehoff M., Beelen D.W. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. Bone Marrow Transplant 2009, 44:295-302.
22. Elmaagacli A.H., Steckel N., Ditschkowski M., et al. Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors. Bone Marrow Transplant 2011, 46:702-708.
23. Taylor P.A., Ehrhardt M.J., Lees C.J., et al. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 2008, 112:3508-3516.
24. Imado T., Iwasaki T., Kitano S., et al. The protective role of host Toll-like receptor-4 in acute graft-versus-host disease. Transplantation 2010, 90:1063-1070.
25. Hossain M.S., Jaye D.L., Pollack B.P., et al. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. J Immunol 2011, 187:5130-5140.
26. Heimesaat M.M., Nogai A., Bereswill S., et al. MyD88/TLR9-mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 2010, 59:1079-1087.
27. Li H., Matte-Martone C., Tan H.S., et al. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol 2011, 186:230-241.
28. Zogas N., Sgouramali E., Iordanidis F., et al. Toll-like receptor 2,4 expression and response to agonist stimulation in patients with acute and chronic graft-versus-host disease. Bone Marrow Transplant 2012, 47(Suppl 1):S12. (abstract 122).
29. Fowler D.H., Foley J., Whit-Shan Hou J., et al. Clinical " cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin Gastroenterol Hepatol 2004, 2:237-245.
30. Randolph G.J., Inaba K., Robbiani D.F., et al. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761.
31. Ziegler-Heitbrock L., Ancuta P., Crowe S., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
32. Sambo P., Jannino L., Candela M., et al. Monocytes of patients with systemic sclerosis scleroderma spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 1999, 112:78-84.
33. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
34. Qian F., Wang X., Zhang L., et al. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 2012, 11:104-110.
35. Wong C.K., Wong P.T.Y., Tam L.S., et al. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 2010, 159:11-22.
36. Vicente-Suarez I., Brayer J., Villagra A., et al. TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses. Immunol Lett 2009, 125:114-118.
37. McGettrick A.F., O'Neill L.A.J. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 2010, 22:20-27.
38. Lun S.W.M., Wong C.K., Ko F.W.S., et al. Expression and functional analysis of Toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol 2009, 29:330-342.
39. + T regulatory cells. J Immunol 2005, 175:8051-8059.
40. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 2007, 19:39-45.
41. + T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation. J Immunol 2009, 182:55-62.
42. + T cells. J Immunol 2005, 175:1551-1557.
43. Wurfel M.M., Gordon A.C., Holden T.D., et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008, 178:710-720.
44. Funderburg N.T., Jadlowsky J.K., Lederman M.M., et al. The Toll-like receptor 1/2 agonists Pam(3)CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-kB signalling patterns in human monocytes. Immunology 2011, 134:151-160.
45. Sutmuller R.P., den Brok M.H., Kramer M., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006, 116:485-494.
46. She K., Gilman A.L., Aslanian S., et al. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007, 13:386-397.
47. Kim W.U., Sreih A., Bucala R. Toll-like receptors in systemic lupus erythematosus prospects for therapeutic intervention. Autoimmun Rev 2009, 8:204-208.
48. Zhang Q., Raoof M., Chen Y., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.